Key result
PTSD symptoms in patients with implantable cardioverter-defibrillators significantly increased long-term mortality risk compared to those without PTSD (HR 3.45; 95% CI 1.57-7.60; P=.002).
Why the study?
Do PTSD symptoms predict long-term mortality risk in patients with implantable cardioverter-defibrillators?
Population
147 patients with implantable cardioverter-defibrillators who qualified for the 'A' criterion of PTSD…
Comparison
Presence of PTSD symptoms vs Absence of significant PTSD symptoms
Design
Cohort
Follow-up
mean 5.1 years
Authors
Loading...
PTSD symptoms warrant clinical attention in ICD patients; leaves open whether screening or treatment improves survival.
Cohort (n=147)
No
Do PTSD symptoms predict long-term mortality risk in patients with implantable cardioverter-defibrillators?
Hazard Ratio: 3.45 (95% CI 1.57–7.6)
Absolute Event Rate: 80% vs 55%
p-value: p=.002
PTSD symptoms in ICD patients are associated with a significantly increased risk of long-term mortality, independent of cardiac disease severity.
Ladwig et al. (2008) conducted a cohort in Patients with implantable cardioverter-defibrillators (ICDs) (n=147). Posttraumatic stress disorder (PTSD) symptoms vs. Patients without PTSD symptoms was evaluated on Long-term mortality risk (HR 3.45, 95% CI 1.57-7.60, p=.002). PTSD symptoms in patients with implantable cardioverter-defibrillators significantly increased long-term mortality risk compared to those without PTSD (HR 3.45; 95% CI 1.57-7.60; P=.002).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: